Latest — Peptides

FDA’s 503B GLP-1 Bulks Proposal: What It Would Exclude

FDA proposed not to place semaglutide, tirzepatide, or liraglutide on the 503B Bulks List. The proposal is not a final ban or drug recall.

August 30, 2026 · 5 min read

The community

Bodybuilders, veterans, medical professionals & IFBB pros

The articles are the reference — the forum is where it gets real. Cycles, bloodwork, training logs, source talk.

Visit the forum